News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update, page-7

And Dr Bradley Glover has now left Celularity to become the COO at IMU.

He also mentioned to me that he was astounded when he found that the 2 best cancer treatments in the world were both owned by a little company in Sydney called OMUGENE.

He is an expert in Cellular Therapies so I wasn’t in any position to argue with him.
It’s certainly smells like IMUGENE is about to show the world what they’ve been cooking up in the lab!

Is this going to be the major event that PH said would launch us onto the Nasdaq.

I’ve posted before how the US Investors are hungry for game changing disruptive technologies to plough money into. Imugene certainly fits the criteria.